“We are very pleased by the overwhelmingly favorable surgeon feedback on the versatility and stable fixation characteristics of Re+Line,” said Rod K. Mayer, president and CEO of the company, in a press release. “This is important to us given the multiple techniques utilized by forefoot surgeons in bunion correction surgery today. Consequently, we anticipate that Re+Line’s unique, low-profile, tension-band plate design will to continue to expand in its applications as we gain more market experience.”
Nextremity Solutions is a privately held medical device company focusing on solutions and approaches for the correction of forefoot pathologies.
More Articles on Devices:
5 Key Results: LDR’s Mobi-C Artificial Disc Replacement vs. ACDF
FDA Clears AccelSPINE’s Next Generation Minimally Invasive Spine System
Global Medical Device Market to Grow at 6.2% Annually Until 2018
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
